Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 4 studies | 31% ± 8% | |
fibroblast | 3 studies | 33% ± 21% | |
hepatocyte | 3 studies | 45% ± 23% |
Insufficient scRNA-seq data for expression of MASP1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 11072.72 | 226 / 226 | 94% | 21.01 | 381 / 406 |
prostate | 97% | 5084.27 | 238 / 245 | 86% | 10.20 | 432 / 502 |
brain | 67% | 638.17 | 1774 / 2642 | 98% | 36.38 | 690 / 705 |
uterus | 99% | 14317.64 | 169 / 170 | 20% | 1.22 | 92 / 459 |
kidney | 26% | 183.02 | 23 / 89 | 81% | 12.49 | 731 / 901 |
intestine | 89% | 6173.37 | 855 / 966 | 9% | 0.54 | 45 / 527 |
bladder | 90% | 2021.52 | 19 / 21 | 6% | 0.54 | 29 / 504 |
heart | 96% | 4137.28 | 827 / 861 | 0% | 0 | 0 / 0 |
skin | 81% | 1844.08 | 1470 / 1809 | 5% | 0.31 | 25 / 472 |
lung | 76% | 922.56 | 442 / 578 | 6% | 0.28 | 73 / 1155 |
blood vessel | 72% | 1052.58 | 965 / 1335 | 0% | 0 | 0 / 0 |
thymus | 67% | 615.91 | 438 / 653 | 1% | 0.02 | 4 / 605 |
adipose | 63% | 812.35 | 754 / 1204 | 0% | 0 | 0 / 0 |
esophagus | 45% | 448.80 | 653 / 1445 | 4% | 0.14 | 8 / 183 |
adrenal gland | 33% | 291.84 | 84 / 258 | 12% | 1.14 | 27 / 230 |
ovary | 41% | 406.41 | 73 / 180 | 2% | 0.18 | 9 / 430 |
breast | 34% | 284.97 | 158 / 459 | 1% | 0.04 | 9 / 1118 |
muscle | 23% | 199.40 | 184 / 803 | 0% | 0 | 0 / 0 |
stomach | 12% | 71.93 | 44 / 359 | 9% | 0.36 | 25 / 286 |
pancreas | 0% | 0 | 0 / 328 | 7% | 0.67 | 12 / 178 |
tonsil | 0% | 0 | 0 / 0 | 7% | 0.18 | 3 / 45 |
spleen | 2% | 18.97 | 6 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 1.10 | 2 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0001867 | Biological process | complement activation, lectin pathway |
GO_0031638 | Biological process | zymogen activation |
GO_0005615 | Cellular component | extracellular space |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005576 | Cellular component | extracellular region |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0008233 | Molecular function | peptidase activity |
GO_0048306 | Molecular function | calcium-dependent protein binding |
GO_0005509 | Molecular function | calcium ion binding |
GO_0005515 | Molecular function | protein binding |
GO_0004252 | Molecular function | serine-type endopeptidase activity |
Gene name | MASP1 |
Protein name | MBL associated serine protease 1 Mannan-binding lectin serine protease 1 (EC 3.4.21.-) (Complement factor MASP-3) (Complement-activating component of Ra-reactive factor) (Mannose-binding lectin-associated serine protease 1) (MASP-1) (Mannose-binding protein-associated serine protease) (Ra-reactive factor serine protease p100) (RaRF) (Serine protease 5) [Cleaved into: Mannan-binding lectin serine protease 1 heavy chain; Mannan-binding lectin serine protease 1 light chain] |
Synonyms | PRSS5 CRARF1 CRARF |
Description | FUNCTION: Functions in the lectin pathway of complement, which performs a key role in innate immunity by recognizing pathogens through patterns of sugar moieties and neutralizing them. The lectin pathway is triggered upon binding of mannan-binding lectin (MBL) and ficolins to sugar moieties which leads to activation of the associated proteases MASP1 and MASP2. Functions as an endopeptidase and may activate MASP2 or C2 or directly activate C3 the key component of complement reaction. Isoform 2 may have an inhibitory effect on the activation of the lectin pathway of complement or may cleave IGFBP5. Also plays a role in development . . |
Accessions | ENST00000169293.10 [P48740-3] F8W876 C9JLU5 ENST00000439271.1 ENST00000707993.1 [P48740-2] ENST00000707990.1 [P48740-1] P48740 ENST00000296280.11 [P48740-2] ENST00000392472.6 [P48740-4] ENST00000425937.1 C9J1C7 ENST00000392470.6 C9JMA2 ENST00000392475.2 ENST00000707996.1 [P48740-3] ENST00000707994.1 [P48740-4] ENST00000337774.10 [P48740-1] |